Luciole Medical AG is developing a unique, next-generation platform of brain monitoring sensors to rapidly provide important information allowing the proper diagnostic and monitoring of compromised oxygen supply conditions and complications. The platform is using proprietary complex algorithm to analyze large set of data and extract clinically relevant information. The company obtained the CE mark for a minimally invasive NIRS probe for ICU and for a NIRS patch for external measurement of brain oxygenation parameters. The Swiss-based private company is a spin out from the Swiss Federal Institute of Technology Zurich (ETH) and the University Hospital of Zurich.